ATE334705T1 - Enzymabhängige therapeutische wundverbände - Google Patents

Enzymabhängige therapeutische wundverbände

Info

Publication number
ATE334705T1
ATE334705T1 AT03756550T AT03756550T ATE334705T1 AT E334705 T1 ATE334705 T1 AT E334705T1 AT 03756550 T AT03756550 T AT 03756550T AT 03756550 T AT03756550 T AT 03756550T AT E334705 T1 ATE334705 T1 AT E334705T1
Authority
AT
Austria
Prior art keywords
enzyme
wound dressings
therapeutic wound
dependent therapeutic
cross
Prior art date
Application number
AT03756550T
Other languages
English (en)
Inventor
Patrick Trotter
Derek Silcock
Original Assignee
Johnson & Johnson Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johnson & Johnson Medical Ltd filed Critical Johnson & Johnson Medical Ltd
Application granted granted Critical
Publication of ATE334705T1 publication Critical patent/ATE334705T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/402—Anaestetics, analgesics, e.g. lidocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/432—Inhibitors, antagonists
    • A61L2300/434—Inhibitors, antagonists of enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A61L2300/604—Biodegradation

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT03756550T 2002-10-01 2003-10-01 Enzymabhängige therapeutische wundverbände ATE334705T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0222722A GB2393656B (en) 2002-10-01 2002-10-01 Enzyme-sensitive therapeutic wound dressings

Publications (1)

Publication Number Publication Date
ATE334705T1 true ATE334705T1 (de) 2006-08-15

Family

ID=9945076

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03756550T ATE334705T1 (de) 2002-10-01 2003-10-01 Enzymabhängige therapeutische wundverbände

Country Status (7)

Country Link
US (1) US20060269590A1 (de)
EP (1) EP1545637B1 (de)
AT (1) ATE334705T1 (de)
AU (1) AU2003299184A1 (de)
DE (1) DE60307299T2 (de)
GB (1) GB2393656B (de)
WO (1) WO2004030711A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2311818T3 (es) 2003-04-28 2009-02-16 JOHNSON & JOHNSON MEDICAL LTD. Apositos terapeuticos sensibles al dolor.
GB2408207A (en) 2003-11-24 2005-05-25 Johnson & Johnson Medical Ltd Wound dressing for the controlled release of therapeutic agents comprising also an inhibitor of a protease enzyme & a linker group cleavable by such an enzyme
WO2005077056A2 (en) * 2004-02-10 2005-08-25 Integrated Botanical Technologies Methods and compositions for the treatment of inflammation
US8383415B2 (en) * 2005-10-13 2013-02-26 Dso National Laboratories Hydrogel composition to enhance fluorescence
US7794495B2 (en) * 2006-07-17 2010-09-14 Advanced Cardiovascular Systems, Inc. Controlled degradation of stents
US8133484B2 (en) 2006-12-15 2012-03-13 Lifebond Ltd Hemostatic materials and dressing
CN101854960B (zh) 2006-12-15 2014-06-25 生命连结有限公司 明胶-转谷氨酰胺酶止血敷料和密封材料
WO2009097508A2 (en) * 2008-01-30 2009-08-06 Mcanulty, Jonathan Methods and compositions for wound healing
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
US20090269405A1 (en) * 2008-04-08 2009-10-29 Appian Labs, Llc Enzyme mediated delivery system
AU2009261559B2 (en) 2008-06-18 2014-01-16 Lifebond Ltd Improved cross-linked compositions
US20100010102A1 (en) * 2008-07-09 2010-01-14 Board Of Regents, The University Of Texas System Triggered release of drugs from polymer particles
EP2963111A1 (de) 2009-12-22 2016-01-06 Lifebond Ltd Modifizierung von enzymatischen vernetzern zur steuerung der eigenschaften vernetzter matrizen
DK2600910T3 (en) 2010-08-05 2016-04-04 Lifebond Ltd Wound dressings and adhesives COMPREHENSIVE DRYING FORMATIONS
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
EP3010419B1 (de) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vakuumerweiterte trockenzusammensetzung und spritze zum zurückhalten davon
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ/エス 押し出し増強因子を含んでいる乾燥組成物
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
EP3436820A2 (de) * 2016-03-30 2019-02-06 Qualizyme Diagnostics GmbH&Co KG Nachweis von mikrobiellen infektionen in wunden
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática
US11998654B2 (en) 2018-07-12 2024-06-04 Bard Shannon Limited Securing implants and medical devices

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405606A (en) * 1981-05-04 1983-09-20 Evreka, Inc. Method for arresting fulminating infection
DK158336C (da) * 1987-09-22 1990-10-01 Coloplast As Forbindsmateriale til behandling af saar samt smaalegemer til brug ved fremstilling deraf
CA1322169C (en) * 1988-04-22 1993-09-14 Hiroshi Yamazaki Ionic dressing of topical administration of drugs to wounds and burns
US5098417A (en) * 1990-04-12 1992-03-24 Ricoh Kyosan, Inc. Cellulosic wound dressing with an active agent ionically absorbed thereon
US6565842B1 (en) * 1995-06-07 2003-05-20 American Bioscience, Inc. Crosslinkable polypeptide compositions
GB2321191B (en) * 1997-01-17 2000-09-27 Johnson & Johnson Medical Peptides for use in wound treatment
GB2340235A (en) * 1998-08-05 2000-02-16 Johnson & Johnson Medical Ltd Monitoring bacterial contamination of a wound involving assay of adenosine triphosphate
US6627785B1 (en) * 2000-02-29 2003-09-30 Virginia Commwealth University Wound dressings with protease-lowering activity
US20020156437A1 (en) * 2000-12-22 2002-10-24 Kimberly-Clark Worldwide, Inc. Removal of targeted proteases with proteinaceous wound dressings containing growth factors
ES2311818T3 (es) * 2003-04-28 2009-02-16 JOHNSON & JOHNSON MEDICAL LTD. Apositos terapeuticos sensibles al dolor.

Also Published As

Publication number Publication date
DE60307299T2 (de) 2007-10-18
DE60307299D1 (de) 2006-09-14
GB2393656A (en) 2004-04-07
WO2004030711A1 (en) 2004-04-15
EP1545637B1 (de) 2006-08-02
GB2393656B (en) 2005-11-16
GB0222722D0 (en) 2002-11-06
AU2003299184A1 (en) 2004-04-23
EP1545637A1 (de) 2005-06-29
US20060269590A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
DE60307299D1 (de) Enzymabhängige therapeutische wundverbände
ATE403448T1 (de) Schmerz-empfindliche therapeutische wundverbände
DK1487493T3 (da) Konjugater af cytotoksiske midler og biologisk aktive peptider
DE602004019299D1 (de) Wundverbände für die kontrollierte freisetzung von therapeutischen mitteln
ATE461217T1 (de) Glp-1-verbindungen
CY1110516T1 (el) Αναστρεψιμα απενεργοποιημενη οξινισμενη πλασμινη
ATE474617T1 (de) Medizinproduktsysteme
ATE511393T1 (de) Transdermale fentanylapplikation
DK1349856T3 (da) Isoindolin-1-on-glucokinase-aktivatorer
ATE342097T1 (de) Elektroaktive pore
CY1108446T1 (el) Μη νευροτοξικοι παραγοντες ενεργοποιησης πλασμινογονου για την αντιμετωπιση αποπληξιας
NO20044898L (no) Nye etonogestrel estere
SE9904377D0 (sv) Pharmaceutical combinations
TW200531787A (en) Polishing system comprising a highly branched polymer
DE60305522D1 (de) Pharmazeutische zusammensetzung enthaltend tenatoprazol und einen entzündungshemmer
BR0304933A (pt) Curativo de ferida
UY28531A1 (es) Composición líquida biologicamente estable de fviii, de fww o del complejo fviii/fww humanos
ATE404602T1 (de) Wässrige polyurethanzubereitungen
DK1713438T3 (da) Medicinsk sæbe
DE602005013530D1 (de) Dentalkleberzusammensetzung
NO20015922L (no) Nye calpainer og anvendelse derav
UY29136A1 (es) Uso de epotilonas en el tratamiento de metastasis osea
UA2826U (uk) Спосіб лікування розсіяного склерозу
DK200000263Y6 (da) Bandage til behandling af tryksår, liggesår og lignede lidelser.
DE60118703D1 (de) Menschliche neurexin-ähnliche proteine und dafür kodierende polynukleotide

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties